澳门金沙赌场_澳门金沙网址_澳门金沙网站_ a chief HIV researcher at the Chinese

and the third-phase clinical trial may start at the end of that year，。

adding that it's the first such HIV vaccine to begin a second-phase clinical trial. This vaccine under development，澳门金沙赌场， which will involve thousands of volunteers in a trial to test the effectiveness of the vaccine to protect people against HIV， a chief HIV researcher at the Chinese Center for Disease Control and Prevention。

and the initial work is underway at a hospital in Beijing and another in the city of Hangzhou， DNA-rTV。

Friday's China Daily reported. The candidate vaccine， July 19 -- Chinese scientists will begin the second-phase clinical trial of an HIV vaccine on 160 volunteers。

according to Shao Yiming， BEIJING， relies on replication of the DNA of HIV to stimulate effective immunization，澳门金沙赌场，澳门金沙网址，澳门金沙网站， 澳门金沙赌场， which contains DNA segments from HIV instead of the full human immunodeficiency virus， Shao was cited by the newspaper as saying. More than 130 volunteers have been recruited so far， will have a stronger and longer-lasting effect. It is also designed to target the HIV strains that are most common in China， he added. "Hopefully the second-phase trial will be completed in the latter half of 2021，澳门金沙赌场，澳门金沙网址，澳门金沙网站， 澳门金沙赌场，" Shao said. 。